take this with a grain of salt
the bull market died today around 2 pm
and we are going to get absolutely whacked here
this is for entertainment purposes only
no one knows for sure
Posted 23 June 2020 - 06:07 PM
take this with a grain of salt
the bull market died today around 2 pm
and we are going to get absolutely whacked here
this is for entertainment purposes only
no one knows for sure
Posted 23 June 2020 - 06:41 PM
'IF' the lower turquoise line breaks it measures about 300 points on the downside of the wedge, I think it's going to happen...
Posted 23 June 2020 - 06:55 PM
Bull flag on the vix...
Edited by Russ, 23 June 2020 - 06:59 PM.
Posted 23 June 2020 - 07:22 PM
Patience... a little pause came in the middle of a hurricane.
This is Russell Rebalance and Reconstitution week, ending on Friday
The VOLUME IS HUGE... RECORD VOLUME...
This plays out into Friday at the close, when record amounts of previously undisclosed and late trades will be registered.
Posted 23 June 2020 - 07:23 PM
Maybe we will just fill the gap at 3180, then tank
Posted 23 June 2020 - 07:34 PM
nearing the end but still too much bearishness around. BUT, the end is nigh for this insane bull run
Posted 23 June 2020 - 07:43 PM
take this with a grain of salt
the bull market died today around 2 pm
and we are going to get absolutely whacked here
this is for entertainment purposes only
no one knows for sure
If the pivot put in around 7PM EDT gets taken out, you might be right.
But if it holds, and YM takes out 26300, then bears are dead as a door nail....they will literally be steamrolled if that happens.
important action dead ahead.....what happens at likely back test of 26100 could be the tell.....
Edited by K Wave, 23 June 2020 - 07:46 PM.
The strength of Government lies in the people's ignorance, and the Government knows this, and will therefore always oppose true enlightenment. - Leo Tolstoy
Posted 23 June 2020 - 07:54 PM
All I can say is do not fight the FED. Watch the news from FED and play the game accordingly.
Posted 23 June 2020 - 08:00 PM
Have a whole bunch of time frames from 1 min to 4hours all coalescing here in this area...
move out of here could be big.....whichever way it breaks
Bulls still have benefit of doubt as long as that 5/15 min combo pivot tonight holds on YM.
The strength of Government lies in the people's ignorance, and the Government knows this, and will therefore always oppose true enlightenment. - Leo Tolstoy
Posted 23 June 2020 - 10:15 PM
BEIJING, June 23, 2020 /PRNewswire/ -- A news report by Qu Jian from Science and Technology Daily:
The Phase I/II clinical trials of the world's first inactivated COVID-19 vaccine, developed by Wuhan Institute of Biological Products under the China National Biotec Group (CNBG) affiliated to the China National Pharmaceutical Group (Sinopharm), produced antibodies in every participant, it was announced on Tuesday.
According to a meeting held simultaneously in Beijing and Henan province on Tuesday, the clinical trial results showed that the vaccination was safe without any serious adverse reaction, and after different procedures and different doses of vaccination were adopted, participants in the vaccine group all produced high titers of antibodies.
People who received two doses of the vaccine at an interval of 28 days, saw their neutralizing antibody positive conversion rate reach 100%.
According to CNBG, the Phase I/II clinical trials were randomized, double-blind, placebo-controlled clinical studies. On April 12, the vaccine obtained the world's first clinical trial approval, and Phase I/II clinical trials were then launched in Wuzhi county of Henan province.
Under the leadership and guidance of the Henan Center for Disease Control and Prevention, the clinical trials were conducted for 66 consecutive days and obtained data on the safety and efficacy of the COVID-19 inactivated vaccine after the administration of the two injections. The data presented research results on different ages, different procedures, different doses, and different injection times in a relatively comprehensive manner. This is also the clinical COVID-19 vaccine research that has the longest time span, produces the most comprehensive data and obtains the best research results, thus providing scientific and evaluable data for epidemic prevention and control as well as emergency use.
CNBG said the study was designed to evaluate the safety and immunogenicity of the COVID-19 inactivated vaccine in healthy subjects aged from 18 to 59 for low, medium and high dosages and injections at intervals of 14, 21 and 28 days.
The study focused on the changes in cellular immunity after vaccination and explored vaccination procedures, immunization dosage, safety, immunogenicity and changes in antibody levels in vivo. Up to now, all the 1,120 subjects that took part in the Phase I/II clinical studies have completed two injections.
For those aged 18 - 59 who received two medium-dose injections through the 14-day and 21-day interval procedures, they had a neutralizing antibody positive conversion rate of 97.6%.
For those who received two medium-dose injections at an interval of 28 days, the neutralizing antibody positive conversion rate reached 100%.
In response to recent new cases in Beijing and the discovery of a new genotype of the virus through whole-genome sequencing, some experts worry that for the new genotype, "the vaccine may weaken or even not work."
However, Yang Xiaoming, chief scientist of the national "863 Program" vaccine project and chairman of CNBG, told Science and Technology Daily he had noticed the new genotype, but it is "still within the coverage of the vaccine whose Phase I/II unblinding occurred today", so it will not affect the effectiveness of the current inactivated vaccine.
CNBG also said that it is now actively developing overseas cooperation in the Phase III clinical research and has confirmed cooperative intentions with companies and institutions in various countries. It has completed building a high biosafety grade production workshop, which is currently the only COVID-19 vaccine production workshop in the world meeting the requirements of biosafety and GMP standards and capable of meeting the needs of widespread emergency vaccination.
https://finance.yaho...-025600458.html